Buying a Home When You Can’t Qualify For Bank Financing

If you’ve previously suffered from financial problems, you may believe there’s little chance to become a homeowner. Prior to the current mortgage industry melt down, an individual who filed bankruptcy could qualify for a home loan in just over a year. But today’s lending climate has made it nearly impossible to qualify for a loan with poor credit.Lenders naturally prefer borrowers with high credit scores. If you have bad credit, don’t give up hope. If you’re willing to expend some effort and time into reestablishing good credit, the good news is you can qualify to buy the home you desire. Plan to set aside six months to two years to reestablish your credit history.If you can convince a potential lender your financial dilemma was due to reasons beyond your control (such as divorce, business failure, medical bills, unemployment) or provide evidence you’ve become financially responsible, you might convince the lender to give you a second chance. But you need to be aware trying to restore your credit requires long-term planning, preparation, and hard effort.On the other hand, if you haven’t filed a bankruptcy or suffered financial problems, but still have other issues affecting your credit such as self employment or a new job less than two years, expect to face an uphill battle trying to qualify for a home loan. Because the mortgage industry is constantly changing, you should speak to a knowledgeable mortgage broker or representative about your available options.Another alternative to traditional financing is to consider owner-will-carry (OWC) financing. If you have no established credit, minimal savings, and a low paying job, this strategy can help you get your foot into the real estate market. Try locating mature homeowners who are fed up with managing their rental properties, but still desired the monthly income a rental property brings. These homeowners make great participants for owner-will-carry financing.By disposing the property to another party, these landlords eliminate the headaches of troublesome tenants, clogged toilets, and malfunctioning air conditioners. They simultaneously earn interest on their seller financed loans which will bring them significantly higher returns than a bank savings account or certificate of deposit.The wonderful aspect about owner or seller financing is the flexibility of lending to anyone the seller desires to, so long as the terms are mutually agreeable. If you can’t qualify for a loan from a regular bank, check out the option of OWC financing as a first choice. Numerous real estate investors and homeowners utilize this alternative without worrying about the hassles of qualifying with a regular lender.

How to Make Winning Medical Nutrition Therapy Goals

A common misconception about type 1 and type 2 diabetes is that there is one common meal and nutritional plan all diabetics can share. Having a customized eating plan and nutritional program is a must for diabetics. Not every person diagnosed with diabetes will have the same Medical Nutrition Therapy (MNT) Goals.Why Are Medical Nutrition Therapy Goals Important?Medical Nutrition Therapy Goals are set to reach your desired metabolic outcome, like blood sugar and HbA1c readings. Proper nutritional therapy can prevent and treat the complications associated with diabetes, improve food choices, and address individual nutritional needs.How Are Medical Nutrition Therapy Goals Determined?MNT goals can be determined by a licensed dietitian, a diabetes educator, or a nurse. The chosen specialist will do a detailed assessment of all aspects of your life… so be prepared. Things taken into consideration when setting MNT goals include:
foods you like/dislike
your job
what you do for fun
typical amount of calories and
regular nutritional intake
How willing you are to make meaningful changes may also be addressed.At the end of your assessment you will have a general idea of how many:
calories/kilojoules you need
calories/kilojoules should come from carbohydrates
grams of protein you need
You should also have been counseled on your activity level and exercise goals, which are an incredibly important part of managing your blood sugar levels.What If You Fall Off Your Nutritional Plan?If you slip up with your nutrition while attempting to reach your Medical Nutrition Therapy Goals don’t feel alone. You have eaten without diabetic restrictions your entire life, so it can be hard to stick with this new healthy lifestyle. If you fall off the wagon, dust yourself off and hop right back on. Try to determine why you couldn’t stick to your nutritional plan and how you can prevent slip-ups in the future.What If Medical Nutrition Therapy Goals Aren’t Being Reached?Benefits of following a customized diabetic meal plan can sometimes be seen in four weeks, however it’s not uncommon for it to take up to three months for positive results to start showing. At a follow up assessment nutritional changes may be made and MNT goals adjusted if results were not as expected.If your body is not responding to your nutritional plan as expected, your dietitian or nutritionist will try to determine the cause. Be sure to tell your specialist if you haven’t been able to follow and stick to your nutritional plan. He may be able to offer alternatives or suggestions that will help you succeed in reaching these goals.If you are not making progress and you feel you are giving it your all, it may be time to find a new specialist. Sometimes the practitioner and you might not “click”… causing important points to fall through the cracks. While you are ultimately accountable for your goals, it’s OK to find another “partner” if the relationship isn’t working out.

S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength

Your stocks to watch for the week ahead are Cheniere Energy (LNG), S&P 500 biotech giant Vertex Pharmaceuticals (VRTX), Cardinal Health (CAH), Steel Dynamics (STLD) and Genuine Parts (GPC).

X
While the market remains in correction, with analysts and investors wary of an economic downturn, these five stocks are worth adding to watchlists. S&P 500 medical giants Vertex and Cardinal Health have been holding up, as health-care related plays tend to do well in down markets.

Steel Dynamics and Genuine Parts are both coming off strong earnings as both the steel and auto parts industries report optimistic outlooks. Meanwhile, Cheniere Energy saw sales boom in the second quarter as demand in Europe for natural gas continues to grow.

Major indexes have been making rally attempts with the Dow Jones and S&P 500 testing weekly support on Friday. With market uncertainty, investors should be ready for follow-through day breakouts and keep an eye on these stocks.

Cheniere Energy, Cardinal Health and VRTX stock are all on IBD Leaderboard.

Cheniere Energy Stock
LNG shares rose 1.1% to 175.79 during Friday’s market trading. On the week, the stock advanced 3.1%, not from highs, bouncing from its 21-day and 10-week lines earlier in the week.

Cheniere Energy has been consolidating since mid-September, but needs another week to forge a proper base, with a potential 182.72 buy point formed on Aug. 10.

Houston-based Cheniere Energy was IBD Stock Of The Day on Thursday, as the largest U.S. producer of liquefied natural gas eyes strong demand in Europe.

Even though natural gas prices are plunging in the U.S. and Europe, investors still see strong LNG demand for Cheniere and others.

The U.K. government confirmed last week that it is in talks for an LNG purchase agreement with a number of companies, including Cheniere.

In the first half of 2021, less than 40% of Cheniere’s cargoes of LNG landed in Europe. That jumped to more than 70% through this year’s second quarter, even as the company ramped up new export capacity. The urgency of Europe’s natural gas shortage only intensified last month. That is when an explosion disabled the Nord Stream 1 pipeline from Russia that had once supplied 40% of the European Union’s natural gas.

In Q2, sales increased 165% to $8 billion and LNG earned $2.90 per share, up from a net loss of $1.30 per share in Q2 2021. The company will report Q3 earnings Nov. 3, with investors seeing booming profits for the next few quarters.

Cheniere Energy has a Composite Rating of 84. It has a 98 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share price movement with a 1 to 99 score. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 41.

Vertex Stock
VRTX stock jumped 3.4% to 300 on Friday, rebounding from a test of its 50-day moving average. Shares climbed 2.2% for the week. Vertex stock has formed a tight flat base with an official buy point of 306.05, according to MarketSmith analysis.

The stock has remained consistent over recent weeks, while the relative strength line has trended higher. The RS line tracks a stock’s performance vs. the S&P 500 index.

Vertex Q3 earnings are on due Oct. 27. Analysts see EPS edging up 1% to $3.61 per share with sales increasing 16% to $2.2 billion, according to FactSet.

The Boston-based global biotech company dominates the cystic fibrosis treatment market. Vertex also has other products in late-stage clinical development that target sickle cell disease, Type 1 diabetes and certain genetically caused kidney diseases. That includes a gene-editing partnership with Crispr Therapeutics (CRSP).

In early August, Vertex reported better-than-expected second-quarter results and raised full-year sales targets.

S&P 500 stock Vertex ranks second in the Medical-Biomed/Biotech industry group. VRTX has a 99 Composite Rating. Its Relative Strength Rating is 94 and its EPS Rating is 99.

CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?

Cardinal Health Stock
CAH stock advanced 3.2% to 73.03 Friday, clearing a 71.22 buy point from a shallow cup-with-handle base and hitting a record high. But volume was light on the breakout. CAH stock leapt 7.3% for the week.

Cardinal Health stock’s relative strength line has also been trending up for months.

The cup-with-handle base is part of a base-on-base pattern, forming just above a cup base cleared on Aug. 11.

Cardinal Health, based in Dublin, Ohio, offers a wide assortment of health care services and medical supplies to hospitals, labs, pharmacies and long-term care facilities. The company reports that it serves around 90% of hospitals and 60,000 pharmacies in the U.S.

S&P 500 stock Cardinal Health will report Q1 2023 earnings on Nov. 4. Analysts forecast earnings falling 26% to 96 cents per share. Sales are expected to increase 10% to $48.3 billion, according to FactSet.

Cardinal Health stock ranks first in the Medical-Wholesale Drug/Supplies industry group, ahead of McKesson (MCK), which is also showing positive action. CAH stock has a 94 Composite Rating out of 99. It has a 97 Relative Strength Rating and an EPS rating of 73.

Steel Dynamics Stock
STLD shares shot up 8.5% to 92.92 on Friday and soared 19% on the week, coming off a Steel Dynamics earnings beat Wednesday night.

Shares blasted above an 88.72 consolidation buy point Friday after clearing a trendline Thursday. STLD stock is 17% above its 50-day line, definitely extended from that key average.

Steel Dynamics’ latest consolidation could be seen as part of a larger base going back six months.

Steel Dynamics topped Q3 earnings views with EPS rising 10% to $5.46 while revenue grew 11% to $5.65 billion. The steel producer’s outlook is optimistic despite weaker flat rolled steel pricing. STLD reports its order activity and backlogs remain solid.

The Fort Wayne, Indiana-based company is among the largest producers of carbon steel products in the U.S. It engages in metal recycling operations along with steel fabrication and produces myriad steel products.

How Millett Grew Steel Dynamics From A Three Employee Business

STLD stock ranks first in the Steel-Producers industry group. STLD stock has a 96 Composite Rating out of 99. It has a 90 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share-price movement that tops at 99. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 98.

Genuine Parts Stock
GPC stock gained 2.8% to 162.35 Friday after the company topped earnings views with its Q3 results on Thursday. For the week GPC advanced 5.1% as the stock held its 50-day line and is in a flat base.

GPC has an official 165.09 flat-base buy point after a three-week rally, according to MarketSmith analysis.

The relative strength line for Genuine Parts stock has rallied sharply to highs over the past several months.

On Thursday, the Atlanta-based auto parts company raised its full-year guidance on growth across its automotive and industrial sales.

Genuine Parts earnings per share advanced 19% to $2.23 and revenue grew 18% to $5.675 billion in Q3. GPC’s full-year guidance is now calling for EPS of $8.05-$8.15, up from $7.80-$7.95. The company now forecasts revenue growth of 15%-16%, up from the earlier 12%-14%.

During the Covid pandemic, supply chain constraints caused a major upheaval in the auto industry, sending prices for new and used cars to record levels. This has made consumers more likely to hang on to their existing vehicles for longer, driving mileage higher and boosting demand for auto replacement parts.

Fellow auto stocks O’Reilly Auto Parts (ORLY) and AutoZone (AZO) have also rallied near buy points amid the struggling market. O’Reilly reports on Oct. 26.

IBD ranks Genuine Parts first in the Retail/Wholesale-Auto Parts industry group. GPC stock has a 96 Composite Rating. Its Relative Strength Rating is 94 and it has an EPS Rating of 89.